Brief: Gentian Diagnostics Says Prioritizes Refinement, Causing Minor Ruo Delay
18/12/2025 08:11
Dec 18 (Reuters) - Gentian Diagnostics ASA GENT.OL: PRIORITIZES REFINEMENT, CAUSING MINOR RUO DELAY EXPECTS TO PROVIDE AN UPDATE ON RUO PRODUCT DURING Q1 OF 2026 Source text: ID:nObiwjWVwa Further company coverage: GENT.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Gentian Diagnostics Q3 Sales At NOK 51.1 Million
Brief: Gentian Diagnostics Q2 EBITDA At NOK 8.1 Mln
Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
Brief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership